New Drug Development & Regulatory News
Shutterstock
Otsuka and Astex Announce the European Commission has Approved INAQOVI
Otsuka Pharmaceutical Europe Ltd. and Astex Pharmaceuticals, Inc. have announce that the European Commission (EC) has approved INAQOVI. Read more
22 Sep 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
Shutterstock
Daiichi and AstraZeneca Breast Cancer Drug Hits Goal
Positive high-level results from the TROPION-Breast01 Phase III trial showed datopotamab deruxtecan (Dato-DXd) demonstrated a statistically significant and clinically meaningful improvement. Read more
22 Sep 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
Shutterstock
Samsung Biologics Announce Agreement with Bristol Myers Squibb to Manufacture an Antibody Cancer Drug Substance
Samsung Biologics announced today a new agreement with Bristol Myers Squibb for large-scale manufacturing of a Bristol Myers Squibb commercial antibody cancer drug substance. Read more
22 Sep 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
Shutterstock
Nulogy and OMP Expand Partnership to Deliver Digital Transformation Experience
Nulogy, a leading provider of supply chain collaboration solutions, and OMP, a global software and services company specialising in optimising supply chain planning, have announced an expansion of their existing partnership. Read more
20 Sep 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
Shutterstock
Verdot Expands Offering with FlexiPro TFF System
Verdot, launches its FlexiPro TFF, a multipurpose tangential flow filtration (TFF) GMP system, in response to rising industry demand for gene therapy, vaccine, and mRNA-based therapeutics. Read more
20 Sep 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
Shutterstock
Pharmanovia Acquires Global CNS Portfolio from Sanofi
Pharmanovia has completed the expansion of its neurology portfolio with the acquisition of 11 central nervous system (CNS) brands from global healthcare company, Sanofi. Read more
20 Sep 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
Shutterstock
New Centre of Excellence to Open in UK
The RNA Centre of Excellence will open on Thursday, 21 September 2023. This will be a new centre to develop cutting-edge vaccines and therapeutics whilst the capability to develop and manufacture treatments for incurable or hard-to-treat illnesses. Read more
21 Sep 2023
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Shutterstock
Future Fields Announces New Paradigm in CDMO Services
Future Fields recently announced the launch of its contract development and manufacturing organisation (CDMO) service. Read more
21 Sep 2023
Shutterstock
Work Begins on £42m Specialist UK Lab Space
Bruntwood SciTech has commenced construction on a £42m, 125,000 sq ft specialist lab and office workspace at the Citylabs cluster to strengthen the internationally significant health innovation campus. Read more
19 Sep 2023
Pharma Manufacturing News + Pharma Finance and Investment News
Shutterstock
Otsuka and Astex Announce the European Commission has Approved INAQOVI
Otsuka Pharmaceutical Europe Ltd. and Astex Pharmaceuticals, Inc. have announce that the European Commission (EC) has approved INAQOVI. Read more
22 Sep 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
Shutterstock
Daiichi and AstraZeneca Breast Cancer Drug Hits Goal
Positive high-level results from the TROPION-Breast01 Phase III trial showed datopotamab deruxtecan (Dato-DXd) demonstrated a statistically significant and clinically meaningful improvement. Read more
22 Sep 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
Shutterstock
Samsung Biologics Announce Agreement with Bristol Myers Squibb to Manufacture an Antibody Cancer Drug Substance
Samsung Biologics announced today a new agreement with Bristol Myers Squibb for large-scale manufacturing of a Bristol Myers Squibb commercial antibody cancer drug substance. Read more
22 Sep 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
TurboFil Expands Development and Demonstration Facility
TurboFil Packaging Machines LLC has substantially expanded the product development and demonstration space at its Mount Vernon, NY headquarters. Read more
22 Sep 2023
Shutterstock
Evecxia Therapeutics and Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treatment
A partnership between Evecxia Therapeutics and Quotient Sciences has resulted in the successful delivery of a Phase 1 clinical testing program for Evecxia’s drug candidate EVX-101, which is in development for major depressive disorder. Read more
22 Sep 2023
Shutterstock
2San Partners With Phoenix Healthcare To Launch Self Diagnostic Tests In UK
2San is partnering with Phoenix Healthcare to allow independent pharmacies to stock an increased range of rapid self-diagnostic products. Read more
21 Sep 2023
Sponsored Content
Optimization of a bio-decontamination process: atomized hydrogen peroxide new cycle development method
Risk-based cycle development, considering not only the required decontamination level but the type of load and cycle total time Read more
3 Feb 2023
11:15
Sponsored Content
Optimization of a bio-decontamination process: atomized hydrogen peroxide new cycle development method
Risk-based cycle development, considering not only the required decontamination level but the type of load and cycle total time Read more
3 Feb 2023
11:15
Natoli Engineering Company, Inc.
Natoli Engineering Company, Inc. has over 44 years of experience in delivering quality tablet compression products and services to the pharmaceutical industry Read more
